Oramed Pharmaceuticals, Inc Live Stock Price Today, Share Analysis and Chart

Name: Oramed Pharmaceuticals, Inc: Is Infosys Ltd. worth buying?
Item: Oramed Pharmaceuticals, Inc
Rating: 1.80458325
Author: Trendlyne DVM scores

about

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form int...

2.34 -0.10 (-4.10%)

28.57% Gain from 52W Low

252.7K

XNAS Volume

High volume today

XNAS 19 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

18.3 / 100

Technically Neutral

53.9 / 100

1Yr Price target upside is 39%

1 analysts

Oramed Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Oramed Pharmaceuticals, Inc Live Stock Price Today, Share Analysis and Chart

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form int...

28.57% Gain from 52W Low

High volume today

SWOT Analysis

Oramed Pharmaceuticals Inc Live Price Chart